Nichi-Iko Closes Acquisition of Teva Takeda’s Generic Biz

February 2, 2021
Nichi-Iko Pharmaceutical said on February 1 that it has completed the acquisition of the generic drug business of Teva Takeda Pharma, a Japanese joint venture between Teva Pharmaceutical Industries and Takeda Pharmaceutical. The Big 3 generic makers announced the acquisition...read more